Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · IEX Real-Time Price · USD
0.893
+0.003 (0.35%)
Jul 22, 2024, 10:18 AM EDT - Market open
Karyopharm Therapeutics Employees
Karyopharm Therapeutics had 325 employees as of December 31, 2023. The number of employees decreased by 60 or -15.58% compared to the previous year.
Employees
325
Change (1Y)
-60
Growth (1Y)
-15.58%
Revenue / Employee
$432,188
Profits / Employee
-$450,262
Market Cap
111.66M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Augmedix | 1,430 |
FONAR | 561 |
TELA Bio | 227 |
I-Mab | 220 |
Adagene | 174 |
RAPT Therapeutics | 131 |
aTyr Pharma | 59 |
Elutia | 54 |
KPTI News
- 17 days ago - XPOVIO® (selinexor) Approved for New Indication in DLBCL in China, Bringing a New Treatment Option to Patients in the Country - PRNewsWire
- 20 days ago - Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 26 days ago - Antengene Announces XPOVIO® (selinexor) National Health Insurance Service Approval for Reimbursement in South Korea - PRNewsWire
- 7 weeks ago - Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Updates - PRNewsWire
- 7 weeks ago - Karyopharm to Participate at the Jefferies Global Healthcare Conference - PRNewsWire
- 2 months ago - Karyopharm to Participate at the 2024 RBC Capital Markets Global Healthcare Conference - PRNewsWire
- 2 months ago - Karyopharm Announces Significant Refinancing Transactions and Amended Royalty Agreement Extending Vast Majority of Its Debt Maturities into 2028 and 2029 - PRNewsWire
- 2 months ago - Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress - PRNewsWire